4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012069
Options or other derivatives
- Chief Financial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012069
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…